Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report

Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report

The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral therapy. Here we report the use of remdesivir in a patient with COVID-19 and the prototypic genetic antibody deficiency X-...

Celý popis

Podrobná bibliografie
Hlavní autoři: Buckland, MS, Galloway, JB, Fhogartaigh, CN, Meredith, L, Provine, NM, Bloor, S, Ogbe, A, Zelek, WM, Smielewska, A, Yakovleva, A, Mann, T, Bergamaschi, L, Turner, L, Mescia, F, Toonen, EJM, Hackstein, C-P, Akther, HD, Vieira, VA, Ceron-Gutierrez, L, Periselneris, J, Kiani-Alikhan, S, Grigoriadou, S, Vaghela, D, Lear, SE, Török, ME, Hamilton, WL, Stockton, J, Quick, J, Nelson, P, Hunter, M, Coulter, TI, Devlin, L, CITIID-NIHR COVID-19 BioResource Collaboration, MRC-Toxicology Unit COVID-19 Consortium, Bradley, JR, Smith, KGC, Ouwehand, WH, Estcourt, L, Harvala, H, Roberts, DJ, Wilkinson, IB, Screaton, N, Loman, N, Doffinger, R, Lyons, PA, Morgan, BP, Goodfellow, IG, Klenerman, P, Lehner, PJ, Matheson, NJ
Médium: Journal article
Jazyk:English
Vydáno: Springer Nature 2020

Podobné jednotky

Podobné jednotky